So while Dr Chan plays around with absolute detailed dosing studies 2+ years after approval
We are now facing possible competition from Fresenius and Dow. It could happen. They have the legal budgets to squash CTSO. So while Fresenius plays hard ball with our stock price, Dr Chan is playing whiffle ball and taking forever to get out dosing studies, success stories and published literature. Maybe its me, but this is getting long in the tooth. Is something wrong?